Taxol(®)-induced phosphatidylserine exposure and microvesicle formation in red blood cells is mediated by its vehicle Cremophor(®) EL. by Vader, P, Fens, M, Sachini, N, van Oirschot, B, Andringa, G, Egberts, A, Gaillard, C, Rasmussen, J, van Wijk, R, van Solinge, W, Schiffelers, R

PI-05: PHARMACODYNAMIC EFFECTS OF AG-946, A HIGHLY POTENT NOVEL ACTIVATOR OF PYRUVATE KINASE, IN EX VIVO TREATMENT OF RED BLOOD CELLS FROM SICKLE CELL DISEASE PATIENTS by RAB M., VAN DIJK M., BOS J., VAN OIRSCHOT B., GERRITS J., KOSINSKI P., KUNG C., JANS J., VAN BEERS E., DANG L., VAN WIJK R.

Get full text

PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE... by VAN DIJK M., RAB M., VAN OIRSCHOT B., BOS J., DERICHS C., RIJNEVELD A., CNOSSEN M., NUR E., BIEMOND B., BARTELS M., JANS J., VAN SOLINGE W., SCHUTGENS R., VAN WIJK R., VAN BEERS E.

Get full text

PI-04: OXYGEN GRADIENT EKTACYTOMETRY-DERIVED BIOMARKERS ARE ASSOCIATED WITH THE OCCURRENCE OF ACUTE COMPLICATIONS IN SICKLE CELL DISEASE by RAB M., KANNE C., BOISSON C., BOS J., VAN OIRSCHOT B., HOUWING M., RENOUX C., SCHUTGENS R., BARTELS M., RIJNEVELD A., NUR E., CNOSSEN M., PHILIPPE J., FORT R., CONNES P., VAN WIJK R., SHEEHAN V., VAN BEERS E.

Get full text